Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Stem Pharm logo — Neuroinflammation-Focused Drug Discovery Using Human Organoi...

Stem Pharm

Neuroinflammation-Focused Drug Discovery Using Human Organoids

Founded 2015 United States Madison, United States 8 employees

General Information

Company Name Stem Pharm
Founded Year 2015
Location United States Madison, United States +1
Employees 8
Social

Get notified when Stem Pharm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Stem Pharm

Stem Pharm is a neurological drug discovery platform company developing the next-generation of neurologic drugs using a human-first approach. Stem Pharm’s proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. The company applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners’ therapeutic programs. Stem Pharm is based in Madison, WI, a hub for innovative stem cell and biosciences research.

No funding data available for Stem Pharm yet.

Get notified when Stem Pharm raises funding

Stem Pharm Alternatives & Competitors

Stem Pharm vs
Aperture Therapeutics
Aperture Therapeutics United States

Diversity. Focus. Discovery.

Pre Seed
4 employees
Biotechnology, Life Sciences
Stem Pharm vs
NeuCyte
NeuCyte United States

Decoding CNS Drug Discovery with SynFire® iP

Series A
11 employees
Biotechnology, Health Care
Stem Pharm vs
Itay&Beyond
Itay&Beyond Israel

Pioneering neuropsychiatric & neurological treatments with brain organoids, functional readouts, and...

14 employees

FAQ About Stem Pharm

Neuroinflammation-Focused Drug Discovery Using Human Organoids
Stem Pharm was founded in 2015.
Stem Pharm is headquartered in Madison, United States.
Stem Pharm has approximately 8 employees.
Top alternatives and competitors to Stem Pharm include Aperture Therapeutics, NeuCyte, Itay&Beyond, BrainXell, Bexorg, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stem Pharm and Aperture Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Stem Pharm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes